Call text draft for the ERDERA Clinical Trial Call, describing governance, scope (in scope/out of scope), funding mechanism, eligibility criteria, application stages (including Stage 0 Expression of Interest and Stage 1 Short Proposal), evaluation, and annexed definitions and indicative timeline. It includes submission deadlines for Expressions of Interest (10 September 2026) and Short Proposals (29 October 2026) and provides a contact email for the Scientific Secretariat.
Version 3.2 | 10th September 2026
This call text may be subject to minor revisions. Applicants are responsible for regularly verifying that they are consulting the latest available version.
